Novel imaging technologies such as PSMA PET/CT are challenging the traditional approaches for staging advanced prostate cancer. These provide exciting possibilities, but further studies are required to establish their true… Click to show full abstract
Novel imaging technologies such as PSMA PET/CT are challenging the traditional approaches for staging advanced prostate cancer. These provide exciting possibilities, but further studies are required to establish their true value in improving patient outcomes.
               
Click one of the above tabs to view related content.